A recent study printed on JD Supra indicated a decline in the number of diagnoses of asbestos-induced mesothelioma over the past forty years. This form of cancer, often attributed to asbestos exposure, has fueled years of litigation and numerous companies seeking bankruptcy protection.
The authors of “Chronological trends in the causation of malignant mesothelioma: Fiber burden analysis of 619 cases over four decades” provide data suggesting a shift in this trend. Asbestos litigation has spanned multiple decades and has commonly been cited as a key reason for many companies to file for bankruptcy protection. Amidst this litigation landscape, many current complaints allege that asbestos exposure is the source of diagnosed mesothelioma cases.
However, the hard data suggested by this exhaustive study may point to a change in asbestos-related health woes. Given the decades-long latency period of diseases like mesothelioma, introducing such a shift makes sense, observing a decline concurrent with the reduction in asbestos use that began in the 1970s.
While this does not suggest an immediate change in the landscape of asbestos litigation, it does hint toward what we can expect in the future. For legal professionals working in corporations and law firms, understanding these medical and scientific developments is crucial to facilitating informed decision-making processes and providing the best possible legal advice to clients and stakeholders.
As we look forward to a future where asbestos-induced mesothelioma may be less prevalent, it’s important to remember the significant challenges and litigation efforts that have led us to this point and the critical role legal professionals in corporations and law firms have played in this journey.